The US Food and Drug Administration (FDA) has accepted Gilead’s new drug application (NDA) for lenacapavir and set a prescription drug user fee act (PDUFA) target action date of ...

In a joint survey by Aidsfonds, GNP+ and the Robert Carr Fund 22% of organizations reported increased experiences of discrimination, including reports of discrimination within healthcare settings, ...

The FDA has accepted Gilead Sciences’ new drug application for lenacapavir as a long-lasting injectable to prevent HIV ...

The U.N.'s Angeli Achrekar reports that many clinics have closed, despite exemptions in the policy. She fears mortality will ...

Researchers at The Wistar Institute's HIV Cure and Viral Diseases Center have successfully identified a new approach using ...

Condoms are among the most effective methods for preventing the sexual transmission of HIV, according to the AIDS Healthcare Foundation (AHF) in Rwanda. AHF Rwanda offers comprehensive services, ...

Lisburn & Castlereagh City Council has joined a global United Nations (UN) drive to help end new diagnoses of HIV: Fast Track Cities.

Offering state HIV patients who qualify a six-month supply of antiretroviral pills at a time is one of the goals in the ...

Human immunodeficiency virus (HIV) treatment has gotten so good that people can take a pill once a day to achieve viral ...

A trial of an earlier, separate vaccine candidate, which was about to be tested on humans in South Africa as well as Kenya ...